Kevin Chou
Examiner (ID: 9940)
Most Active Art Unit | 3785 |
Art Unit(s) | 3785 |
Total Applications | 4 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 4 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 13507795
[patent_doc_number] => 20180305440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => GLYCOPROTEINS WITH ANTI-INFLAMMATORY PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 15/957703
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957703
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957703 | GLYCOPROTEINS WITH ANTI-INFLAMMATORY PROPERTIES | Apr 18, 2018 | Abandoned |
Array
(
[id] => 13510511
[patent_doc_number] => 20180306798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Monitoring Dysregulated Serum Complement, Coagulation, and Acute-Phase Inflammation Sub-Proteomes Associated with Cancer
[patent_app_type] => utility
[patent_app_number] => 15/953260
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953260
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953260 | Monitoring Dysregulated Serum Complement, Coagulation, and Acute-Phase Inflammation Sub-Proteomes Associated with Cancer | Apr 12, 2018 | Abandoned |
Array
(
[id] => 13465169
[patent_doc_number] => 20180284127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => METHOD AND APPARATUS FOR ANALYZING PROTEIN-PROTEIN INTERACTION ON SINGLE-MOLECULE LEVEL WITHIN THE CELLULAR ENVIRONMENT
[patent_app_type] => utility
[patent_app_number] => 15/945890
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6841
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945890 | Method and apparatus for analyzing protein-protein interaction on single molecule level within the cellular environment | Apr 4, 2018 | Issued |
Array
(
[id] => 17939656
[patent_doc_number] => 11474104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
[patent_app_type] => utility
[patent_app_number] => 15/941046
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 32584
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941046
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/941046 | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy | Mar 29, 2018 | Issued |
Array
(
[id] => 16576634
[patent_doc_number] => 20210011035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => A RAPID, ON-DEMAND HEPARIN-INDUCED THROMBOCYTOPENIA FUNCTIONAL ASSAY
[patent_app_type] => utility
[patent_app_number] => 16/498175
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498175
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498175 | A RAPID, ON-DEMAND HEPARIN-INDUCED THROMBOCYTOPENIA FUNCTIONAL ASSAY | Mar 28, 2018 | Abandoned |
Array
(
[id] => 13316875
[patent_doc_number] => 20180209975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS
[patent_app_type] => utility
[patent_app_number] => 15/934368
[patent_app_country] => US
[patent_app_date] => 2018-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15934368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/934368 | METHODS FOR USING EXOSOMES TO MONITOR TRANSPLANTED ORGAN STATUS | Mar 22, 2018 | Pending |
Array
(
[id] => 17605186
[patent_doc_number] => 11333665
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Tissue-derived extracellular vesicles and their use as diagnostics
[patent_app_type] => utility
[patent_app_number] => 16/494193
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 15777
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494193 | Tissue-derived extracellular vesicles and their use as diagnostics | Mar 21, 2018 | Issued |
Array
(
[id] => 15515169
[patent_doc_number] => 10564166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Device and method for detection of analytes
[patent_app_type] => utility
[patent_app_number] => 15/920076
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 81
[patent_no_of_words] => 30026
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920076
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/920076 | Device and method for detection of analytes | Mar 12, 2018 | Issued |
Array
(
[id] => 13431021
[patent_doc_number] => 20180267053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => Systems and Methods for Developing Diagnostic Tests Based on Biomarker Information from Legacy Clinical Sample Sets
[patent_app_type] => utility
[patent_app_number] => 15/918489
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15918489
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/918489 | Systems and Methods for Developing Diagnostic Tests Based on Biomarker Information from Legacy Clinical Sample Sets | Mar 11, 2018 | Abandoned |
Array
(
[id] => 14613481
[patent_doc_number] => 10359435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/910108
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 11
[patent_no_of_words] => 25306
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910108
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910108 | Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof | Mar 1, 2018 | Issued |
Array
(
[id] => 13816341
[patent_doc_number] => 10184936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Activation of bioluminescence by structural complementation
[patent_app_type] => utility
[patent_app_number] => 15/899219
[patent_app_country] => US
[patent_app_date] => 2018-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 204
[patent_figures_cnt] => 204
[patent_no_of_words] => 57918
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/899219 | Activation of bioluminescence by structural complementation | Feb 18, 2018 | Issued |
Array
(
[id] => 18187798
[patent_doc_number] => 11578370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Methods for diagnosis and treatment of patients having solid tumors
[patent_app_type] => utility
[patent_app_number] => 16/485977
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9157
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485977 | Methods for diagnosis and treatment of patients having solid tumors | Feb 13, 2018 | Issued |
Array
(
[id] => 14006027
[patent_doc_number] => 10221453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Advanced detection of sepsis
[patent_app_type] => utility
[patent_app_number] => 15/889035
[patent_app_country] => US
[patent_app_date] => 2018-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 32980
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 354
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15889035
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/889035 | Advanced detection of sepsis | Feb 4, 2018 | Issued |
Array
(
[id] => 15268231
[patent_doc_number] => 20190382849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => METHODS, ARRAYS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/479064
[patent_app_country] => US
[patent_app_date] => 2018-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479064 | METHODS, ARRAYS AND USES THEREOF | Jan 30, 2018 | Abandoned |
Array
(
[id] => 13302947
[patent_doc_number] => 20180203010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => ANGPTL4 AS A PROGNOSTIC MARKER FOR BLADDER CANCER
[patent_app_type] => utility
[patent_app_number] => 15/873593
[patent_app_country] => US
[patent_app_date] => 2018-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873593
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873593 | ANGPTL4 AS A PROGNOSTIC MARKER FOR BLADDER CANCER | Jan 16, 2018 | Abandoned |
Array
(
[id] => 15212827
[patent_doc_number] => 20190369100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => MITOCHONDRIAL PROTEASE OMA1 AS A MARKER FOR BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 16/476961
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16476961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/476961 | MITOCHONDRIAL PROTEASE OMA1 AS A MARKER FOR BREAST CANCER | Jan 11, 2018 | Pending |
Array
(
[id] => 12644955
[patent_doc_number] => 20180106816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => MULTIPLES MULTIPLEX IMMUNOHISTOCHEMICAL ASSAY USING PRIMARY ANTIBODIES OF THE SAME HOST SPECIES
[patent_app_type] => utility
[patent_app_number] => 15/841914
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24341
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841914
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/841914 | Multiples multiplex immunohistochemical assay using primary antibodies of the same host species | Dec 13, 2017 | Issued |
Array
(
[id] => 15041359
[patent_doc_number] => 20190331684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => USE OF IN1-GHRELIN FOR THE DIAGNOSIS OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/470152
[patent_app_country] => US
[patent_app_date] => 2017-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8337
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/470152 | USE OF IN1-GHRELIN FOR THE DIAGNOSIS OF PROSTATE CANCER | Dec 3, 2017 | Abandoned |
Array
(
[id] => 15256481
[patent_doc_number] => 20190376974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHOD FOR ACQUIRING MEDICAL CARE AUXILIARY INFORMATION
[patent_app_type] => utility
[patent_app_number] => 16/464465
[patent_app_country] => US
[patent_app_date] => 2017-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464465
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464465 | METHOD FOR ACQUIRING MEDICAL CARE AUXILIARY INFORMATION | Nov 28, 2017 | Abandoned |
Array
(
[id] => 13253451
[patent_doc_number] => 10139410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Protein-protein interaction as biomarkers
[patent_app_type] => utility
[patent_app_number] => 15/796755
[patent_app_country] => US
[patent_app_date] => 2017-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 46
[patent_no_of_words] => 46873
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15796755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/796755 | Protein-protein interaction as biomarkers | Oct 27, 2017 | Issued |